Suven Life Sciences Limited (SUVEN) — Announcement | 14 July 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Suven Life Sciences schedules investor and analyst meeting for July 17, 2026
💡 Investor Takeaway
This meeting provides investors a chance to hear directly from management about the company's strategy and performance.

Suven Life Sciences announced an upcoming investor and analyst meeting in Mumbai on July 17, 2026, to discuss its business outlook and financial performance, with no unpublished price-sensitive information to be disclosed. The filing confirms the schedule is subject to change and requests exchanges to take it on record.

📄 View Original Announcement (PDF)

About Suven Life Sciences Limited (SUVEN)

Healthcare · Healthcare · Listed on NSE

Market Cap: ₹10,762.81 Cr ROE: -80.9% ROCE: -80.7%

View full SUVEN stock details →

📡 Get AI alerts when SUVEN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SUVEN — Free

📊 More SUVEN filings

See all SUVEN filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SUVEN files new disclosures

Track SUVEN filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SUVEN — Free

Free account · 2 AI queries/day